ArticlePatient preference and adherence2026

Glucosuria as a Biomarker of Adherence to Sodium-Glucose Co-Transporter Protein Type 2 Inhibitors.

José Escribano-Serrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.